Rocket Doctor Further Validates Growth with Maryland Announcements

Rocket Doctor AI (OTCQB: AIRDF) (CSE: AIDR) announced the addition of about 2 million potential patients in Marylandthrough an agreement with a state entity of a major national insurer. The deal comes in the wake of Rocker Doctor officially commencing patient care operations in Maryland, marking a critical milestone in the company's U.S. expansion. The Maryland announcements build on recent Medicaid and Medicare in-network coverage deals across the United States, underscoring Rocket Doctor's strategy to improve access for underserved populations.

But Maryland is just the most recent manifestation of something bigger. Rocket Doctor now covers 21 million in-network potential patients across California, Maryland, and New York, significantly up from where it was at the end of 2025. This rapid scaling validates the company's investment over several years and its focused strategy of building deep market penetration within identified states and across complex healthcare systems.

Watch a recent Stock Therapy interview with CEO Dr. Bill Cherniak, filmed prior to the Maryland announcements. He covers a lot of pertinent issues in just a few minutes. We’ll hit the highlights below the video.

https://youtu.be/Higyoepm_Co?si=IfsGKILWPSN9mkOj

The 97% Virtual Care Management Rate

What makes Rocket Doctor's model compelling to insurers? The company maintains a 97% virtual care management rate, meaning 97% of patients are managed through virtual visits without needing in-person appointments.

"Something like 97% of patients consistently are managed virtually and don't need an in-person visit. It's a no-brainer for plans when you approach them with that data to see how much money they can save by avoiding unnecessary acute care visits that are exponentially more expensive," Cherniak explains.

This cost-savings data is core to Rocket Doctor's value proposition. By keeping patients in virtual care, Rocket Doctor delivers better outcomes while dramatically reducing costs for payers. "Not to mention the care is better, patients are happier, and they don't sit in an ER all day," Cherniak adds.

Strategic Deep Market Expansion

Rocket Doctor is taking a deliberate approach, focusing on California, Maryland, and New York - three of the most complex healthcare markets in the country.

"We've made that intentional decision to go really deep into the very large complex markets we're in and build really strong foundational experience, then that will help us in the future," Cherniak says. Healthcare is "very regionally specific" and government-funded insurance is "heavily regulated," making the deep-market approach essential.

The strategy aligns with Cherniak's personal experience: he trained at Johns Hopkins, practiced in South Baltimore, teaches at USC, and is licensed in all three states.

Maryland: Third Major U.S. Market

Maryland operations officially launched with the first patients being seen following Medicaid and Medicare in-network expansion. Reflecting the perceived growth, Dr. Suzanne Caccamese has been appointed Maryland Medical Lead, bringing clinical training from Penn State College of Medicine and leadership experience from Towson University, MedStar, and the University of Maryland.

Maryland represents a strategic East Coast foothold with approximately 4.6 million people covered through Medicaid and Medicare combined. Combined with California and New York, Rocket Doctor's 21 million in-network lives position the company for accelerated 2026 revenue growth. Currently, the company generates only ~5% of revenue from the U.S. market, suggesting potentially substantial upside as Maryland (and California/New York) ramps up.

Capital Market Confidence

Rocket Doctor recently saw approximately $2 million in warrants exercised, demonstrating shareholder confidence in consistent execution. "I know there's been a lot of uncertainty in the market, and it's great to see actual execution consistently coming out of the Rocket Doctor team," Cherniak says.

Next 6 Months: Patient Acquisition

"More of the same, basically building out our growth marketing funnel to bring on more folks into the ecosystem is what we're up to with patients and providers," Cherniak says. Rocket Doctor is also focused on marketing investment to convert the patients covered by the recently announced agreements into patients on the company’s digital health platform and marketplace.

Rocket Doctor has additional payer partnerships in development:

• Medicare Advantage contracts
• Veterans Affairs partnerships
• Commercial insurance credentialing
• Medicaid Managed Care contracts
  

Investment Thesis

Rocket Doctor represents a health company with proven execution across three major U.S. healthcare markets. The 21 million potential patients covered by in-network agreements and the 97% virtual care management rate create a compelling cost-savings value proposition for winning major payer contracts.

The "deep not broad" strategy in California, Maryland, and New York positions Rocket Doctor to capture market share in government-funded healthcare programs like Medicaid, Medicare, and VA which currently cover about 50% of Americans. With Maryland now live, payer contract announcements being added regularly, and only 5% revenue from the U.S., Rocket Doctor is executing consistently on its growth plan with plenty of upside available.

The company's mission to reach underserved communities aligns with healthcare's push toward equitable, patient-centered care. Utilizing AI and other sophisticated tools to support clinicians in delivering quality care, Rocket Doctor is helping to redefine modern healthcare.

Sponsored Content Disclosure: This article is sponsored by Rocket Doctor AI. SECFilings.com has partnered with the company to help share its story with a broader audience of investors and industry followers. SECFilings.com is being compensated $15,000 USD per quarter by 45 Degrees Inc. While we strive to present accurate information and maintain editorial standards, this content is part of a paid awareness initiative. Please do your own research and consult a licensed advisor before making investment decisions.